PTGS2 and type 2 diabetes mellitus: MiR-200 demonstrates a pro-inflammatory response by its effect on the synthesis of the protein Zeb-1, which is involved in increasing the activity of the cyclooxygenase-2 and monocytic chemotactic protein-1 in vascular smooth muscle cells in type 2 diabetes [40].